Medicortex Finland is dedicated to improving the diagnostics, treatment and prevention of acute neurodegenerative conditions. Current focus is on developing a novel biomarker based diagnostic test for traumatic brain injuries (TBI). After the development project the company will focus on a multiplex treatment for TBI.

Board and Management

The company's founder is Dr. Adrian Harel, an experienced neurobiologist with an impressive track record in leadership of early-stage drug discovery companies and business management. His collaboration with renowned experts in medicinal chemistry promises to generate a successful pipeline of innovative therapeutic molecules and diagnostic biomarkers.

Our Team

Medicortex's CEO, Dr. Adrian Harel, has a PhD in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug R&D know-how and GMP production and manufacturing knowledge. He combines a broad scientific education with extensive industry experience.

Chief Medical Officer, Mårten Kvist has an MD from the University of Helsinki, Finland, and MD/PhD at the University of Turku, Finland. He is an Associate Professor (Docent) in General Practice at the University of Turku and in public Health at the University of Lapland.

Chief Scientific Officer, Lasse Välimaa has a PhD degree in Molecular Biotechnology and Diagnostics at the University of Turku, Finland. His background is in the R&D of bioanalytical methods and medical diagnostics.

Chief Operating Officer, Oskar Haavisto has a MSc degree in Molecular Biotechnology and Diagnostics at the University of Turku, Finland. He has practical experience and scientific know-how in the diagnostic immunoassay field and therapeutic antibody development. He has prior experience in coordinating scientific research projects. He has previously worked as a clinical research coordinator. 

Product Manager, Dr. Begum Utz has a PhD in biological sciences from Vanderbilt University in Nashville, TN, USA. She has key experience in life sciences R&D project management and data analysis. Dr. Utz is responsible for technical planning and development of the diagnostic kit, integration of the chemistry into the assembly and transfer of the prototype from development to the production. 

Research Assistant, Jesper Lindholm, has a MSc in Cell Biology, from Åbo Akademi. 

Laboratory Assistant Venla-Mari Nurmi is studying Biomedicine at the University of Turku. 

Our Financial Manager is KLT-accountant Marjukka Iitti. Also a partner and member of the board in Tili-Vinkki Oy.

The Team 3

'

Scientific and Clinical Advisory Board (SAB)

Heikki Rauvala - MD, PhD, Professor. Neuroscience Center, University of Helsinki, Finland. Chairman of the SAB.

Professor Rauvala has published about 220 frequently cited publications relating to his primary research interests; development, plasticity and regeneration of the central nervous system; injuries of the central nervous system and behavioral disorders.

Antti Kaipia - MD, PhD, Professor. Chief at the Department of Urology, Tampere University Hospital, Finland.

Dr. Kaipia is a specialist in surgery and urology. He has a vast experience in clinical practices of central hospitals.

Lauri Kangas - PhD, Associate Professor.

Dr. Kangas has his background in the pharmaceutical industry. He is retired from his latest position as a Chief Scientific Officer in a drug development company where he was one of the founders. Currently he is serving as a Scientific Adviser at several new drug development companies in the Turku Region in Finland.

Timo Kurki  - MD, PhD, Associate Professor.

Dr. Kurki is a specialist in neuroradiology with special interest in diagnostics of brain injury and multiple sclerosis. He is the Chief of Medical Imaging services at Terveystalo Oy, one of the main private clinics in Finland.

Risto O. Roine - MD, PhD, Professor in Neurology and Chief Physician, Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Finland.

Professor Roine has held several chief managerial positions in Neurology, for example, the Chairman of the Division of Clinical Neurosciences at Turku University Hospital. He has served as an Investigator in 40 clinical trials. He has published 99 peer-reviewed original articles as well as dozens of reviews or book chapters.

Markku Tuominen – MD, PhD. Chief Physician and CEO of Medisport Oy, Finland.

Dr. Tuominen is an experienced physician and key opinion leader in sports injuries. He is a member of the Medical Committee of the International Ice Hockey Federation (IIHF) and he is serving as a physician in the Finnish Ice Hockey Federation.


Board of Directors

Chariman of the Board - Dr. Adrian Harel

Member Associate Professor Mårten Kvist, MD, PhD, Medical Director

Member Tom Palenius, Interim CEO, Turku Science Park Ltd.